AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024

Currently Viewing Abstracts from 2005

Title
A 6-MONTH PLACEBO-CONTROLLED STUDY OF VENLAFAXINE XR IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents
A Naturalistic, Retrospective Evaluation of Aripiprazole Use in Child and Adolescent Psychiatric Inpatients
A Psychoeducation Program that Reduces Metabolic Syndrome Risk Factors in the Severe and Persistently Mentally Ill
A retrospective evaluation of metabolic indices in patients who switched atypical antipsychotic agents
Abuse of psychotropic medication in the correctional setting: identification, assessment and harm reduction through education & formulary changes
ACUTE WEIGHT GAIN WITH COMBINATION DIVALPROEX SODIUM AND OLANZAPINE IN CHILDREN AND ADOLESCENT INPATIENTS AT A UNIVERSITY HOSPITAL
ADAMANTANE DERIVATIVE (MEMANTINE): PHARMACOKINETICS IN HEALTHY AND RENALLY IMPAIRED SUBJECTS
Adherence to American Psychiatric Association Practice Guidelines for the Treatment of Patients with Severe Acute Mania
Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia
ADVERSE EVENTS DURING ANTIPSYCHOTIC CLINICAL TRIALS OF ELDERLY PATIENTS WITH DEMENTIA
An assessment of safety, preference, effectiveness, quality of life, and tolerability (SPEQT) in patients with epilepsy switched from immediate-release to extended-release carbamazepine capsules
Analog Classroom Study of Amphetamine Extended Release and Atomoxetine in Youth with ADHD
Analysis of the Efficacy of Venlafaxine vs Placebo in A Subgroup of Patients With Moderate or Severe Major Depression
ANTIDEPRESSANT MEDICATION MANAGEMENT IN DEPRESSION PATIENTS: A ROLE FOR CLINICAL PHARMACISTS
Antidepressants and risk of falls
Antipsychotic Polypharmacy: Pharmacoepidemiology and Potential Predictors of Utilization
Antipsychotics and Side Effect Burden: A Prospective Study Comparing Antipsychotic Monotherapy Versus Combination Therapy
ARIPIPRAZOLE BIOEQUIVALENCE: ORALLY DISINTEGRATING TABLET COMPARED TO TABLET FORMULATION
Aripiprazole induced seizure in an adolescent
Assessment of Patient Satisfaction with Sustained-release Antidepressant Use in a Family Practice Setting: Pilot Study of Antidepressant Survey
ASSOCIATION BETWEEN MEDICATION CHANGES AND FALLS IN GERIATRIC PSYCHIATRY PATIENTS
Association of Anxiety Symptoms with Treatment Outcomes Among Outpatients With Major Depression
ATOMOXETINE EFFICACY FOR SEVERE HYPERACTIVE AND INATTENTIVE ADHD SYMPTOMS
ATOMOXETINE’S EFFICACY OVER TIME IN CHILDREN AND ADOLESCENTS WITH ADHD
Atypical Antipsychotic Agents & Risk Factors for Diabetes Mellitus: Comparing Schizophrenic & Bipolar Disorder Patients
CARDIOVASCULAR EFFECTS OF EXTENDED-RELEASE MIXED AMPHETAMINE SALTS IN CHILDREN WITH ADHD
CARDIOVASCULAR EFFECTS OF MIXED AMPHETAMINE SALTS XR IN ADULT ADHD
Centralized Pharmaceutical Care Consultations in a Regional State Psychiatric Facility
Clinical and Economic Outcomes Associated with the Use of Long Acting Risperidone Injection in a Texas Community Mental Health Clinic
CLINICAL RELEVANCE OF DEPRESSIVE SYMPTOM IMPROVEMENT IN BIPOLAR DEPRESSED PATIENTS TREATED WITH OLANZAPINE-FLUOXETINE COMBINATION
CONCERNS OF MENTAL HEALTH CONSERVATORSHIP ATTORNEYS REGARDING PSYCHOTROPIC MEDICATION USE -- IMPLICATIONS FOR PRACTITIONERS
Continuity of Antipsychotic Pharmacotherapy Among Medicaid Recipients
Delirium in Long-Term Care Residents Predicted by an Anticholinergic Drug Rating Scale and Not Serum Anticholinergic Activity
Development and Implementation of Computerized Staff Training Modules to Teach Psychopharmacology
Development of Aligorithms for Three Main Axis I Disorders ( Schizophrenia, Bipolar Disorder and Major Depression) in a Community Based Mental Health Facility
Development of Doctor of Pharmacy Industry Advanced Practice Experience
Double-Blind, Placebo-Controlled Study of Quetiapine in Bipolar Depression
DULOXETINE AT DOSES OF 60 MG QD AND 60 MG BID IS FFECTIVE IN TREATMENT OF DIABETIC NEUROPATHIC PAIN (DNP)
DULOXETINE VS. PLACEBO IN THE TREATMENT OF ELDERLY PATIENTS WITH MDD
Effect of Food on the Bioavailability of Galantamine Extended-Release (ER) Capsule and Pharmacokinetic Comparison of Galantamine ER with Galantamine Immediate-Release (IR) Tablet
EFFECT OF MEMANTINE ON BEHAVIORAL OUTCOMES IN MILD TO SEVERE ALZHEIMER’S DISEASE
EFFICACY AND TOLERABILITY OF DULOXETINE: COMPARISON OF 30 MG QD AND 60 MG QD STARTING DOSES
EFFICACY OF ARIPIPRAZOLE IN SUB-POPULATIONS OF BIPOLAR DISORDER PATIENTS WITH ACUTE MANIA: A POOLED ANALYSIS
ELECTROCARDIOGRAPHIC EVALUATION OF INTRAMUSCULAR ZIPRASIDONE IN CHILDREN AND ADOLESCENTS
ELEVEN YEAR INTERIM RESULTS OF AN INTERNATIONAL OBSERVATIONAL STUDY OF PREGNANCY OUTCOMES FOLLOWING EXPOSURE TO LAMOTRIGINE
Evaluation of an activation syndrome associated with the initiation of aripiprazole in children and adolescent inpatients admitted to a psychiatric unit at a university medical center
Evaluation of the Time Course of Reversal of Valproate Mediated Inhibition of Lamotrigine
Evaluation of ziprasidone mesylate guidelines for use at the medical university of south carolina (MUSC)
Extended-Release Carbamazepine for Treatment of Manic and Mixed Symptoms
GENETIC ANALYSIS OF THE RELATIONSHIP BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR AND SCHIZOPHRENIA
GLYCEMIC CONTROL OF PSYCHIATRIC PATIENTS ON ATYPICAL ANTIPSYCHOTICS AND HYPOGLYCEMICS: A DRUG UTILIZATION EVALUATION
IMMEDIATE SWITCHING OF ANTIDEPRESSANT THERAPY:RESULTS FROM A CLINICAL TRIAL OF DULOXETINE
Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital
Implementation of Safe Medication Practices Using Computer Technology in a Behavioral Health Acute Care Hospital
Increased Risk of Mortality Associated with Psychotropic Drug Use in VA Patients Admitted for Pneumonia.
Increased Utilization of Ziprasidone Decreased Daily Antipsychotic Costs in an Inpatient Unit
Infection risk among patients receiving long-term clozapine treatment.
Insight into Medication Knowledge and Reasons for Nonadherence as Reported by Patients with Mental Illness
Introduction of an Opiate Review Committee into a Restricted Access Health Care System
LONG-TERM EFFECTS OF ATOMOXETINE ON GROWTH IN CHILDREN WITH ADHD
Long-Term Efficacy and Safety of Galantamine Extended Release for the Treatment of Mild to Moderate Alzheimer’s Disease
MEMANTINE DECREASES THE LEVELS OF ALZHEIMER β-AMYLOID PROTEINS IN RAT PRIMARY CORTICAL NEURONS AND HUMAN NEUROBLASTOMA CELLS
METABOLIC MONITORING WITH ATYPICAL ANTIPSYCHOTICS: IMPACT OF PUBLISHED GUIDELINES
Off-label use of Selective Serotonin Reuptake Inhibitors in a Family Medicine Practice
Open-Label Trial of Escitalopram in the Treatment of PTSD
OVERALL TREATMENT EFFECTIVENESS AS MEASURED BY TIME CONTINUING ON ANTIPSYCHOTIC THERAPY
OVERALL TREATMENT EFFECTIVENESS AS MEASURED BY TIME CONTINUING ON ANTIPSYCHOTIC THERAPY
Pharmacoeconomics and Design of Optimal Dosage Regimens
PRESCRIBING PATTERNS OF ATYPICAL ANTIPSYCHOTICS IN PATIENTS DISCHARGED FROM A UNIVERSITY BASED PSYCHIATRIC HOSPITAL
Prevention of Panic Disorder Relapse in Adult Outpatient Responders to Treatment with Venlafaxine XR
QUALITY-OF-LIFE ASSESSMENT IN ATOMOXETINE-TREATED ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Quetiapine for the Treatment of Agitation in Institutionalized Patients with Dementia: A Randomized, Double-Blind Trial
Rehospitalization Rates during Conditional Release in Mentally Ill Forensic Commitments: A Retrospective Study
Relationship Between Sub-therapeutic Dosing of Atypical Antipsychotic Agents and Use of Adjunct Antidepressant and Antianxiety Agents
Retrospective Analysis of Extended-Release Divalproex for Schizophrenia and Mood Related Disorders in an Inpatient Mentally Ill Population
SAFETY AND EFFICACY OF MAS XR IN ADOLESCENTS WITH ADHD
SAFETY AND EFFICACY OF MIXED AMPHETAMINE SALTS EXTENDED RELEASE IN CHILDREN AND ADOLESCENTS WITH OPPOSITIONAL DEFIANT DISORDER (ODD)
Serotonin 5HT2A (-1438G/A and T102C) and G-protein beta subunit (GNB3 C825T) polymorphisms and SSRI-associated sexual dysfunction
Switch rate comparison among antidepressant agents
Switching form immediate-release to extended-release carbamazepine capsules: safety and tolerability in adolescents with epilepsy
Switching Patients With Alzheimer’s Disease From Galantamine Immediate-Release to Extended-Release Formulation: A Pharmacokinetic Simulation
Symptom profiles of prepubertal children with a diagnosis of ADHD, bipolar disorder, or a depressive disorder
THE EFFECT OF PHARMACEUTICAL CARE INVOLVING REINFORCEMENT OF NON-PHARMACOLOGICAL TREATMENT ON ABSTINENCE IN BUPRENORPHINE TREATED PATIENTS
The Effect of Second Generation Antipsychotics on Weight Gain in Children and Adolescents
The Prevalence of Co-Morbid Physical Illness in State Hospital Inpatients with Schizophrenia
The use of the adverse event profile for evaluating tolerabilty of carbamazepine therapy given as immediate-release and extended-release formulations
Tolerability of Escitalopram in the Treatment of Social Anxiety Disorder
Treatment of Manic and Mixed Patients with Extended-Release Carbamazepine
UPDATE OF MEMANTINE SAFETY IN SHORT- AND LONG-TERM TREATMENT OF DEMENTIA
Venlafaxine XR and Paroxetine in the Short-Term Treatment of Panic Disorder